DK1461049T3 - Anvendelse af sulfaterede glycosaminoglykoner til etablering af effektiv födsel hos kvinder - Google Patents
Anvendelse af sulfaterede glycosaminoglykoner til etablering af effektiv födsel hos kvinderInfo
- Publication number
- DK1461049T3 DK1461049T3 DK03700633T DK03700633T DK1461049T3 DK 1461049 T3 DK1461049 T3 DK 1461049T3 DK 03700633 T DK03700633 T DK 03700633T DK 03700633 T DK03700633 T DK 03700633T DK 1461049 T3 DK1461049 T3 DK 1461049T3
- Authority
- DK
- Denmark
- Prior art keywords
- pregnant woman
- labor
- myometrium
- cervix
- molecular weight
- Prior art date
Links
- 210000003679 cervix uteri Anatomy 0.000 abstract 3
- 210000000754 myometrium Anatomy 0.000 abstract 3
- 239000003055 low molecular weight heparin Substances 0.000 abstract 2
- 229940127215 low-molecular weight heparin Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004411 Antithrombin III Human genes 0.000 abstract 1
- 108090000935 Antithrombin III Proteins 0.000 abstract 1
- 229960005348 antithrombin iii Drugs 0.000 abstract 1
- 238000009109 curative therapy Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000014508 negative regulation of coagulation Effects 0.000 abstract 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 abstract 1
- 230000037452 priming Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200005A SE521676C2 (sv) | 2002-01-02 | 2002-01-02 | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
| PCT/SE2003/000004 WO2003055499A1 (en) | 2002-01-02 | 2003-01-02 | Use of sulfated glycosaminoglycans for establishing effective labor in women |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1461049T3 true DK1461049T3 (da) | 2008-09-15 |
Family
ID=20286575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03700633T DK1461049T3 (da) | 2002-01-02 | 2003-01-02 | Anvendelse af sulfaterede glycosaminoglykoner til etablering af effektiv födsel hos kvinder |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US7407945B2 (de) |
| EP (1) | EP1461049B1 (de) |
| JP (1) | JP4434741B2 (de) |
| KR (1) | KR100958691B1 (de) |
| CN (1) | CN100341518C (de) |
| AT (1) | ATE395067T1 (de) |
| AU (1) | AU2003201787B2 (de) |
| CA (1) | CA2472093C (de) |
| CY (1) | CY1108260T1 (de) |
| DE (1) | DE60320931D1 (de) |
| DK (1) | DK1461049T3 (de) |
| ES (1) | ES2306852T3 (de) |
| HK (1) | HK1076389A1 (de) |
| IL (2) | IL162664A0 (de) |
| NO (1) | NO332702B1 (de) |
| NZ (1) | NZ533856A (de) |
| PL (1) | PL206458B1 (de) |
| PT (1) | PT1461049E (de) |
| SE (1) | SE521676C2 (de) |
| SI (1) | SI1461049T1 (de) |
| WO (1) | WO2003055499A1 (de) |
| ZA (1) | ZA200405015B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE521676C2 (sv) | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
| WO2005007223A2 (en) * | 2003-07-16 | 2005-01-27 | Sasha John | Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations |
| WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| CN104144950B (zh) * | 2011-12-19 | 2017-09-05 | 迪乐方有限责任公司 | 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途 |
| US20150057226A1 (en) * | 2012-03-26 | 2015-02-26 | Dilafor Ab | Method for treatment of labor arrest |
| CN104203256B (zh) * | 2012-03-26 | 2017-11-24 | 迪乐方有限责任公司 | 用于引产的包含硫酸化的葡糖胺聚糖的联合治疗 |
| UA117912C2 (uk) * | 2012-05-08 | 2018-10-25 | Ділафор Аб | Застосування гепарину або гепарансульфату для лікування післяпологової кровотечі (ппк) |
| KR20150039201A (ko) | 2012-08-03 | 2015-04-09 | 엘에프비 유에스에이, 인크. | 체외 막 산소공급에서의 안티트롬빈의 용도 |
| US20230144378A1 (en) | 2020-02-17 | 2023-05-11 | Dilafor Ab | Tafoxiparin for the treatment of preeclampsia |
| TW202406559A (zh) | 2022-05-03 | 2024-02-16 | 瑞典商迪拉佛公司 | 塔夫西肝素(tafoxiparin)之新穎醫藥用途 |
| EP4272749A1 (de) | 2022-05-03 | 2023-11-08 | Dilafor AB | Neue medizinische verwendung von tafoxiparin |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223263A (en) * | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
| EP0209924A1 (de) * | 1985-07-12 | 1987-01-28 | Akzo N.V. | Antithrombotikum auf Basis von Glykosaminoglykan, Verfahren zu dessen Herstellung und pharmazeutische Zusammensetzung |
| US4916122A (en) * | 1987-01-28 | 1990-04-10 | University Of Georgia Research Foundation, Inc. | 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition |
| US5190926A (en) * | 1987-01-28 | 1993-03-02 | University Of Georgia Research Foundation, Inc. | 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents |
| SE8702254D0 (sv) | 1987-05-29 | 1987-05-29 | Kabivitrum Ab | Novel heparin derivatives |
| GB8719367D0 (en) * | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
| US5470838A (en) * | 1987-10-28 | 1995-11-28 | Pro-Neuron, Inc. | Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine |
| US6020322A (en) * | 1993-11-09 | 2000-02-01 | Pro-Neuron, Inc. | Acyl deoxyribonucleoside derivatives and uses thereof |
| US5736531A (en) * | 1987-10-28 | 1998-04-07 | Pro-Neuron, Inc. | Compositions of chemotherapeutic agent or antiviral agent with acylated pyrimidine nucleosides |
| US5968914A (en) * | 1987-10-28 | 1999-10-19 | Pro-Neuron, Inc. | Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
| US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| US5256641A (en) * | 1990-11-01 | 1993-10-26 | State Of Oregon | Covalent polar lipid-peptide conjugates for immunological targeting |
| US5543390A (en) * | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Covalent microparticle-drug conjugates for biological targeting |
| US5543389A (en) * | 1990-11-01 | 1996-08-06 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University, A Non Profit Organization | Covalent polar lipid-peptide conjugates for use in salves |
| US5149794A (en) * | 1990-11-01 | 1992-09-22 | State Of Oregon | Covalent lipid-drug conjugates for drug targeting |
| US5280016A (en) | 1991-03-29 | 1994-01-18 | Glycomed Incorporated | Non-anticoagulant heparin derivatives |
| US5554728A (en) * | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
| SE9302135D0 (sv) * | 1993-06-18 | 1993-06-18 | Kabi Pharmacia Ab | New pharmaceutical composition |
| US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
| US5559101A (en) * | 1994-10-24 | 1996-09-24 | Genencor International, Inc. | L-ribofuranosyl nucleosides |
| ES2276404T3 (es) * | 1995-06-07 | 2007-06-16 | Emory University | Nucleosidos con actividad antivirus de la hepatitis-b. |
| US6025335A (en) * | 1995-09-21 | 2000-02-15 | Lipitek International, Inc. | L-Nucleoside Dimer Compounds and therapeutic uses |
| US5767269A (en) * | 1996-10-01 | 1998-06-16 | Hamilton Civic Hospitals Research Development Inc. | Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics |
| NZ330603A (en) * | 1996-10-15 | 2000-01-28 | Toray Industries | Hyaluronic acid derivatives used as cervical ripening agents |
| JP4412756B2 (ja) | 1998-02-26 | 2010-02-10 | 生化学工業株式会社 | 新規多糖誘導体、その製造法及びそれを有効成分とする医薬組成物 |
| US6194391B1 (en) * | 1998-06-24 | 2001-02-27 | Emory University | 3′-azido-2′,3′-dideoxyuridine administration to treat HIV and related test protocol |
| IL127896A0 (en) * | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
| JP2000309544A (ja) * | 1999-02-25 | 2000-11-07 | Seikagaku Kogyo Co Ltd | 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤 |
| SE521676C2 (sv) | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
-
2002
- 2002-01-02 SE SE0200005A patent/SE521676C2/sv unknown
-
2003
- 2003-01-02 NZ NZ53385603A patent/NZ533856A/xx not_active IP Right Cessation
- 2003-01-02 SI SI200331314T patent/SI1461049T1/sl unknown
- 2003-01-02 AT AT03700633T patent/ATE395067T1/de active
- 2003-01-02 DE DE60320931T patent/DE60320931D1/de not_active Expired - Lifetime
- 2003-01-02 CN CNB038019442A patent/CN100341518C/zh not_active Expired - Fee Related
- 2003-01-02 WO PCT/SE2003/000004 patent/WO2003055499A1/en active IP Right Grant
- 2003-01-02 DK DK03700633T patent/DK1461049T3/da active
- 2003-01-02 IL IL16266403A patent/IL162664A0/xx unknown
- 2003-01-02 EP EP03700633A patent/EP1461049B1/de not_active Expired - Lifetime
- 2003-01-02 PT PT03700633T patent/PT1461049E/pt unknown
- 2003-01-02 PL PL370428A patent/PL206458B1/pl unknown
- 2003-01-02 KR KR1020047010488A patent/KR100958691B1/ko active IP Right Grant
- 2003-01-02 CA CA2472093A patent/CA2472093C/en not_active Expired - Fee Related
- 2003-01-02 AU AU2003201787A patent/AU2003201787B2/en not_active Ceased
- 2003-01-02 ES ES03700633T patent/ES2306852T3/es not_active Expired - Lifetime
- 2003-01-02 US US10/500,284 patent/US7407945B2/en not_active Expired - Fee Related
- 2003-01-02 JP JP2003556076A patent/JP4434741B2/ja not_active Expired - Fee Related
-
2004
- 2004-06-21 IL IL162664A patent/IL162664A/en not_active IP Right Cessation
- 2004-06-24 ZA ZA2004/05015A patent/ZA200405015B/en unknown
- 2004-07-27 NO NO20043190A patent/NO332702B1/no not_active IP Right Cessation
-
2005
- 2005-09-26 HK HK05108458A patent/HK1076389A1/xx not_active IP Right Cessation
-
2008
- 2008-07-07 US US12/168,683 patent/US8207145B2/en not_active Expired - Fee Related
- 2008-08-13 CY CY20081100861T patent/CY1108260T1/el unknown
-
2012
- 2012-05-09 US US13/467,918 patent/US8524688B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1076389A1 (en) | Use of sulfated glycosaminoglycans for the manufacture of a pharmaceutical preparation for the prevention and treatment of slow progress of term labor | |
| BRPI0511603A (pt) | método para o tratamento de distúrbios do sangramento com a utilização de polissacarìdeos sulfatados | |
| Shaughnessy et al. | The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria | |
| Kuderer et al. | Guidelines for treatment and prevention of venous thromboembolism among patients with cancer | |
| WO2005055944A3 (en) | Oligosaccharide compositions and use thereof in the treatment of infection | |
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| SG149875A1 (en) | Use of low-dose erythropoietin for the treatment of acute or chronic kidney failure and for the treatment of wounds | |
| KR20160088914A (ko) | 새로운 만성 궤양 치료제 | |
| MX2007011002A (es) | Composicion farmaceutica que comprende la combinacion de diversos agentes venotonicos y vasoprotectores para el tratamiento de la insuficiencia venosa cronica. | |
| ATE419857T1 (de) | Verwendung von abführmittel zur behandlung des reizdarmsyndroms | |
| ES2141922T3 (es) | Tiazepinonas de benzotiofeno, benzofurano e indol, oxazepinonas y diazepinonas usadas como inhibidores de la adherencia celular y del vih. | |
| Thodiyil et al. | Thromboprophylaxis in the cancer patient | |
| Caprini et al. | The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery | |
| DE60143078D1 (de) | Pax2 zur behandlung von nierenkrankheiten | |
| WO2005060960A3 (en) | Use of histamine to treat bone disease | |
| WO2005044189A3 (en) | Dialysates and methods and systems related thereto | |
| HUP0401188A2 (hu) | Hiperelágazásos amilopektin sebészeti, gyógyító vagy diagnosztikai eljárásokban emlősöknél való alkalmazásra, különösen plazmatérfogat-növelőként | |
| ATE302008T1 (de) | Behandlung von entzündlichen erkrankungen | |
| Bergqvist | Update on in hospital venous thromboembolism prophylaxis | |
| BR0111900A (pt) | Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca | |
| ATE324905T1 (de) | Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall | |
| Poseryaev et al. | METHODS OF CONSERVATIVE TREATMENT OF VENOUS TROPHIC ULCERS ON THE OUTPATIENT STAGE | |
| Ahmed et al. | The Use of Hyaluronic Acid in Reducing Postoperative Complications in Minor Oral Surgery: A Review | |
| Manjra | Venous leg ulcers: a literature review | |
| GR1003885B (el) | Μη-πεπτιδικοι μιμητες της δραστικης αλληλουχιας s42fllr46 του υποδοχεα της θρομβινης για την θεραπεια της θρομβωσης και του καρκινου |